Anupam Rasayan to acquire 43.3%–48.2% equity stake in Bliss GVS Pharma
The acquisition marks Anupam Rasayan’s strategic entry into the pharmaceutical formulations segment
The acquisition marks Anupam Rasayan’s strategic entry into the pharmaceutical formulations segment
Net profit stood at Rs. 921 crore for the quarter, while Europe revenues surged 30.2% YoY to Rs. 2,795 crore
Q4FY26 revenue rises 13.6% to Rs. 14,560 crore; quarterly net profit jumps 26.2% to Rs. 2,714 crore driven by India business and Innovative Medicines growth
Eris Lifesciences posts sharp profit surge in FY26 driven by strong diabetes portfolio growth
She brings extensive expertise in managing global and domestic procurement operations
Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
Doshi has established a strong track record in driving quality assurance, regulatory compliance, and formulation excellence across complex pharmaceutical operations
US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya
Subscribe To Our Newsletter & Stay Updated